Company / Shares Outstanding
Corvus Pharmaceuticals, Inc. Shares Outstanding History
FY2015-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Shares Outstanding
61.0M
FY2024
5-year range
29.5M / 61.0M
FY2020-FY2024
Trend
+27.0%
vs FY2023
Sector context
#144 of 212
Health Care
What the data says
At 60985165.00, Corvus Pharmaceuticals, Inc.'s shares outstanding ranks #69 of 212 in the Health Care sector. Shares Outstanding has increased for 9 consecutive years, from 373643.00 in FY2015 to 60985165.00 in FY2024.
Based on SEC 10-K filings.
60985165.00 in FY2024 with a 5-year CAGR of +15.8%.
Increased from 46553511.00 to 60985165.00 over the past 2 years.
Health Care sector context is included.
Shares Outstanding over time
Growth rates
- 3-Year CAGR
- +13.4%
- 5-Year CAGR
- +15.8%
- 10-Year CAGR
- -
Sector benchmark
#69 of 212 in Health CareTop 32% of 212This company 61.0M Sector average 306.3M
▼
-80.1% below sector average
Key checks
Key Insights
- Corvus Pharmaceuticals, Inc.'s shares outstanding has grown for 9 consecutive years.
- In FY2024, shares outstanding increased 27.0% year-over-year.
- Ranks #144 out of 212 companies in the Health Care sector.
- Lowest shares outstanding in the period was in FY2015.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score -0.67 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Shares OutstandingValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | 61.0M | +27.0% |
| FY2023 | 48.0M | +3.2% |
| FY2022 | 46.6M | +11.2% |
| FY2021 | 41.9M | +42.0% |
| FY2020 | 29.5M | +0.4% |
| FY2019 | 29.3M | +6.7% |
| FY2018 | 27.5M | +34.3% |
| FY2017 | 20.5M | +32.9% |
| FY2016 | 15.4M | +4027.5% |
| FY2015 | 373.6K | +119.4% |
As of FY2024 · SEC 10-K · Updated Feb 28, 2026